INVO BioScience, Inc.

The momentum for this stock is not very good. INVO BioScience, Inc. is not a good value stock. INVO BioScience, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in INVO BioScience, Inc..

News

INVO Stock Earnings: INVO Bioscience Reported Results for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nINVO Bioscience just reported results for the second quarter of 2024.\nThe post INVO Stock Earnings: INVO Bioscience Reported Results for...\n more…

INVO Bioscience reports Q2 EPS (62c) vs. ($3.06) last year

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA

Globe Newswire SARASOTA, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...\n more…

INVO Bioscience files for $100M mixed shelf

SeekingAlpha.com: All News INVO Bioscience files prospectus for $100M mixed securities shelf offering; not an offer to sell the securities.\n more…

INVO Bioscience files $100M mixed securities shelf

INVO Stock Earnings: INVO Bioscience Reported Results for Q1 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nINVO Bioscience just reported results for the first quarter of 2024.\nThe post INVO Stock Earnings: INVO Bioscience Reported Results for...\n more…